189 related articles for article (PubMed ID: 32735610)
1. Gene expression profile analysis of the rabbit retinal vein occlusion model.
Neo T; Gozawa M; Takamura Y; Inatani M; Oki M
PLoS One; 2020; 15(7):e0236928. PubMed ID: 32735610
[TBL] [Abstract][Full Text] [Related]
2. Photocoagulation of the Retinal Nonperfusion Area Prevents the Expression of the Vascular Endothelial Growth Factor in an Animal Model.
Gozawa M; Takamura Y; Miyake S; Matsumura T; Morioka M; Yamada Y; Inatani M
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5946-5953. PubMed ID: 29098298
[TBL] [Abstract][Full Text] [Related]
3. Acute variations in retinal vascular oxygen content in a rabbit model of retinal venous occlusion.
Jaime GR; Kashani AH; Saati S; Martin G; Chader G; Humayun MS
PLoS One; 2012; 7(11):e50179. PubMed ID: 23185567
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling in a mouse model of retinal vein occlusion induced by laser treatment reveals a predominant inflammatory and tissue damage response.
Martin G; Conrad D; Cakir B; Schlunck G; Agostini HT
PLoS One; 2018; 13(3):e0191338. PubMed ID: 29529099
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion.
Zeng Y; Cao D; Yu H; Zhuang X; Yang D; Hu Y; He M; Zhang L
Mol Vis; 2019; 25():756-765. PubMed ID: 31814701
[TBL] [Abstract][Full Text] [Related]
6. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion.
Jung SH; Kim KA; Sohn SW; Yang SJ
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091
[TBL] [Abstract][Full Text] [Related]
7. Alterations in protein tyrosine kinase pathways following retinal vein occlusion in the rat.
Hayashi A; Kim HC; de Juan E
Curr Eye Res; 1999 Mar; 18(3):231-9. PubMed ID: 10342378
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.
Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E
Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233
[TBL] [Abstract][Full Text] [Related]
9. IL-18 and S100A12 Are Upregulated in Experimental Central Retinal Vein Occlusion.
Cehofski LJ; Kruse A; Kirkeby S; Alsing AN; Ellegaard Nielsen J; Kojima K; Honoré B; Vorum H
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30366444
[TBL] [Abstract][Full Text] [Related]
10. PD0325901, a mitogen-activated protein kinase kinase inhibitor, produces ocular toxicity in a rabbit animal model of retinal vein occlusion.
Huang W; Yang AH; Matsumoto D; Collette W; Marroquin L; Ko M; Aguirre S; Younis HS
J Ocul Pharmacol Ther; 2009 Dec; 25(6):519-30. PubMed ID: 19929595
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of NSP-116, a free radical scavenger, suppresses the symptoms of retinal vein occlusion in the murine model.
Yamamoto T; Nitta K; Nishinaka A; Tanaka M; Nakamura S; Shimazawa M; Hara H
Exp Eye Res; 2021 Mar; 204():108453. PubMed ID: 33503450
[TBL] [Abstract][Full Text] [Related]
12. Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion.
Avrutsky MI; Ortiz CC; Johnson KV; Potenski AM; Chen CW; Lawson JM; White AJ; Yuen SK; Morales FN; Canepa E; Snipas S; Salvesen GS; Jean YY; Troy CM
Nat Commun; 2020 Jun; 11(1):3173. PubMed ID: 32576823
[TBL] [Abstract][Full Text] [Related]
13. Ischemic retinal vein occlusion: characterizing the more severe spectrum of retinal vein occlusion.
Khayat M; Williams M; Lois N
Surv Ophthalmol; 2018; 63(6):816-850. PubMed ID: 29705175
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an Anti-Semaphorin 3A Neutralizing Antibody in a Male Experimental Retinal Vein Occlusion Mouse Model.
Nakamura S; Nishinaka A; Hidaka Y; Shimazawa M; Thomas L; Bakker RA; Hara H
Invest Ophthalmol Vis Sci; 2022 Jul; 63(8):14. PubMed ID: 35822950
[TBL] [Abstract][Full Text] [Related]
15. Microglia Activation and Recruitment of Circulating Macrophages During Ischemic Experimental Branch Retinal Vein Occlusion.
Ebneter A; Kokona D; Schneider N; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):944-953. PubMed ID: 28170538
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inflammatory cells delays retinal degeneration in experimental retinal vein occlusion in mice.
Jovanovic J; Liu X; Kokona D; Zinkernagel MS; Ebneter A
Glia; 2020 Mar; 68(3):574-588. PubMed ID: 31652020
[TBL] [Abstract][Full Text] [Related]
17. Effect of Fufang Xueshuantong Capsule on a rat model of retinal vein occlusion.
Yuan YZ; Yuan F; Xu QY; Yu J; Li L; Zhang JL
Chin J Integr Med; 2011 Apr; 17(4):296-301. PubMed ID: 21509674
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of anti-VEGF-A/Ang-2 bispecific antibody on retinal vein occlusion model mice.
Kuriyama A; Nakamura S; Inokuchi Y; Abe H; Yasuda H; Hidaka Y; Nagaoka K; Soeda T; Shimazawa M; Hara H
Eur J Pharmacol; 2024 Aug; 976():176691. PubMed ID: 38821166
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion.
Campochiaro PA; Bhisitkul RB; Shapiro H; Rubio RG
Ophthalmology; 2013 Apr; 120(4):795-802. PubMed ID: 23260261
[TBL] [Abstract][Full Text] [Related]
20. Effects of ripasudil, a ROCK inhibitor, on retinal edema and nonperfusion area in a retinal vein occlusion murine model.
Hida Y; Nakamura S; Nishinaka A; Inoue Y; Shimazawa M; Hara H
J Pharmacol Sci; 2018 Jun; 137(2):129-136. PubMed ID: 29983234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
